Mechanistic basis of increased susceptibility to nephrotoxicants in chronic liver disease

Keyphrases

• Increased Vulnerability 100%
• Chronic Liver Disease 100%
• Nephrotoxic Medications 100%
• Xenobiotics 33%
• Elimination Method 33%
• Drug-metabolizing Enzymes 33%
• Pharmacokinetics 16%
• Nephrotoxicity 16%
• Pharmacokinetic Profile 16%
• Patient Outcomes 16%
• Public Health Risk 16%
• Renal Elimination 16%
• Nonalcoholic Steatohepatitis 16%
• Drug Disposition 16%
• Systemic Exposure 16%
• Renal Physiology 16%
• Expression Change 16%
• Hepatic Dysfunction 16%
• Global Prevalence 16%
• Biliary Excretion 16%
• Membrane Transporters 16%
• Adverse Drug Reaction 16%
• Alcoholic Liver Disease 16%
• Hepatic Elimination 16%
• Viral Hepatitis 16%
• Decreased Glomerular Filtration Rate 16%
• Drug Elimination 16%
• Xenobiotic Disposition 16%
• Liver Disease Etiology 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Chronic Liver Disease 100%
• Elimination 50%
• Xenobiotic Agent 50%
• Pharmacokinetics 33%
• Drug Metabolizing Enzyme 33%
• Nephrotoxicity 16%
• Prevalence 16%
• Ethanol 16%
• Liver Dysfunction 16%
• Nonalcoholic Fatty Liver 16%
• Liver Disease 16%
• Adverse Drug Reaction 16%
• Biliary Excretion 16%
• Virus Hepatitis 16%